Entera Bio Ltd. (ENTX)
NASDAQ: ENTX
· Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT
Entera Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.09M | -9.54M | -9.18M | -8.54M | -8.72M | -8.89M | -9.93M | -10.62M | -11.48M | -13.07M | -5.12M | -4.51M | -6.48M | -12.19M | -19.35M | -18.52M | -16.55M |
Depreciation & Amortization | 41K | 46K | 48K | 51K | 55K | 56K | 59K | 61K | 62K | 64K | -81K | -65K | -22K | 53K | 255K | 274K | 266K |
Stock-Based Compensation | 2.7M | 2.56M | 2.31M | 1.76M | 1.64M | 1.69M | 1.85M | 1.57M | 1.8M | 2.25M | 2.14M | 2.57M | 2.5M | 1.86M | 1.69M | 1.07M | 855K |
Other Working Capital | 484.57K | 188.57K | -716.39K | -421.39K | -489.68K | -543.68K | 852K | 328K | -51K | -1.62M | -2.53M | -2.1M | -1.92M | -143K | -123K | -553K | -596K |
Other Non-Cash Items | 703.47K | 1.2M | 1.29M | 1.28M | 578.29K | 77.29K | -24K | -13K | -42K | -78K | -8.91M | -9.59M | -7.1M | 74K | 8.82M | 8.71M | 5.9M |
Deferred Income Tax | 14K | 14K | -103.35 | 28.9K | 28.9K | 28.9K | 52K | 237K | 207K | 174K | -66K | -286K | -254K | -273K | -67K | -69K | -81K |
Change in Working Capital | 425.15K | 112.15K | -1.12M | -605.75K | -530.63K | -163.63K | 1.29M | 709K | 135K | -1.83M | -1.11M | -454K | -217K | 1.41M | 856K | -57K | -434K |
Operating Cash Flow | -6.33M | -6.79M | -7.83M | -7.2M | -7.45M | -7.2M | -6.7M | -8.05M | -9.32M | -12.5M | -13.14M | -12.33M | -11.58M | -9.06M | -7.8M | -8.59M | -10.04M |
Capital Expenditures | 1K | 9K | 7.22K | -4.6K | -5.6K | -16.6K | -14.81K | -17K | -35K | -47K | -54K | -59K | -40K | -17K | -9K | -24K | -24K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 374.86 | -54.63K | -54.63K | -54.63K | -55K | n/a | n/a | n/a | -33K | -33K | -33K |
Investing Cash Flow | -11K | -3K | -4.78K | -4.6K | -5.6K | -16.6K | -14.81K | -72K | -90K | -102K | -109K | -59K | -40K | -17K | -42K | -57K | -57K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -51K | -100K | -145K | -168K | -158K | -144K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.21M | -99K | -537K | -550K | -545K | -575K | 5K | 5K | 13K | 13K | 179K | 352K | 3.57M | 3.87M | 3.7M | 3.53M | 297.57K |
Financial Cash Flow | 17.77M | 4.47M | 7.28M | 7.27M | 6.07M | 6.04M | 4.83K | 4.81K | 12.81K | 12.81K | 33.9K | 2.62M | 15.27M | 25.38M | 28.31M | 25.9M | 13.2M |
Net Cash Flow | 11.41M | -2.28M | -592K | 24K | -1.41M | -1.27M | -6.71M | -8.12M | -9.39M | -12.59M | -13.01M | -9.61M | 3.77M | 16.37M | 20.33M | 17.16M | 3.05M |
Free Cash Flow | -6.34M | -6.79M | -7.84M | -7.21M | -7.46M | -7.22M | -6.72M | -8.06M | -9.35M | -12.55M | -13.2M | -12.39M | -11.62M | -9.08M | -7.81M | -8.61M | -10.07M |